# Candel Therapeutics, Inc.: Form 8-K, filed May 15, 2026

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: 8-K
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 16:13 ET
- Period: 2026-05-15
- Accession: 0001193125-26-226751
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000119312526226751/d106447d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000119312526226751/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000119312526226751/d106447d8k.htm

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-226751. Last ingested by Listed: Nov 5, 2026, 18:42 ET. No prices; not investment advice.